LMAT Crosses Above Average Analyst Target

LeMaitre Vascular (LMAT) traded at $110.33, exceeding the average analyst 12-month target of $109.62 by $0.71 (≈0.65%). The note highlights that reaching an analyst target often forces a reaction—such as downgrades or target resets—potentially affecting short-term analyst sentiment and positioning, but this is routine and unlikely to move broad markets.

Analysis

LeMaitre Vascular (LMAT) traded at $110.33, exceeding the average analyst 12-month target of $109.62 by $0.71 (≈0.65%). The note highlights that reaching an analyst target often forces a reaction—such as downgrades or target resets—potentially affecting short-term analyst sentiment and positioning, but this is routine and unlikely to move broad markets.